Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  44,423 results for ""Neoplastic Stem Cells""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The biomarkers for maintenance Cancer stem cell features can be applicable in precision medicine of head and neck squamous cell carcinoma.

Subjects: Neoplastic Stem Cells*/Neoplastic Stem Cells*/Neoplastic Stem Cells*/pathology ; Neoplastic Stem Cells*/Neoplastic Stem Cells*/Neoplastic Stem Cells*/metabolism ; Precision Medicine*/Precision Medicine*/Precision Medicine*/methods

  • Source: Journal of stomatology, oral and maxillofacial surgery [J Stomatol Oral Maxillofac Surg] 2024 Sep; Vol. 125 (4S), pp. 101906. Date of Electronic Publication: 2024 Apr 28.Publisher: Elsevier Masson SAS Country of Publication: France NLM ID: 101701089 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Sphingosine-1 phosphate receptor 1 (S1PR1) expression maintains stemness of acute myeloid leukemia stem cells.

  • Authors : Wang YQ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematological Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.

Subjects: Sphingosine-1-Phosphate Receptors*/Sphingosine-1-Phosphate Receptors*/Sphingosine-1-Phosphate Receptors*/metabolism ; Sphingosine-1-Phosphate Receptors*/Sphingosine-1-Phosphate Receptors*/Sphingosine-1-Phosphate Receptors*/genetics ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/pathology

  • Source: Cancer letters [Cancer Lett] 2024 Sep 28; Vol. 600, pp. 217158. Date of Electronic Publication: 2024 Aug 05.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

CD44/PD-L1-mediated networks in drug resistance and immune evasion of breast cancer stem cells: Promising targets of natural compounds.

  • Authors : Malla R; Cancer Biology Laboratory, Department of Biochemistry and Bioinformatics, School of Science, GITAM (Deemed to be University), Visakhapatnam 530045, Andhra Pradesh, India; Department of Biochemistry and Bioinformatics, School of Science, GITAM (Deemed to be University), Visakhapatnam 530045, Andhra Pradesh, India. Electronic address: .

Subjects: Hyaluronan Receptors*/Hyaluronan Receptors*/Hyaluronan Receptors*/metabolism ; Neoplastic Stem Cells*/Neoplastic Stem Cells*/Neoplastic Stem Cells*/drug effects ; Neoplastic Stem Cells*/Neoplastic Stem Cells*/Neoplastic Stem Cells*/immunology

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 Sep 10; Vol. 138, pp. 112613. Date of Electronic Publication: 2024 Jul 02.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Genetic deletion of JAM-C in preleukemic cells rewires leukemic stem cell gene expression program in AML.

  • Authors : Grenier JMP; Aix Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Equipe Labellisée Ligue 2020, Marseille, France.; UMR 7268, Aix-Marseille Université, EFS, CNRS, GENGLOBE, Marseille, France.

Subjects: Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/genetics ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/metabolism ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/pathology

  • Source: Blood advances [Blood Adv] 2024 Sep 10; Vol. 8 (17), pp. 4662-4678.Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

The dual role of POSTN in maintaining glioblastoma stem cells and the immunosuppressive phenotype of microglia in glioblastoma.

  • Authors : Wang H; Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.; Yao L

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/metabolism ; Glioblastoma*/Glioblastoma*/Glioblastoma*/pathology ; Glioblastoma*/Glioblastoma*/Glioblastoma*/immunology

  • Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Sep 04; Vol. 43 (1), pp. 252. Date of Electronic Publication: 2024 Sep 04.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966

Record details

Read More Add to Saved list
×
Academic Journal

Acid-sensing ion channel 3 is a new potential therapeutic target for the control of glioblastoma cancer stem cells growth.

  • Authors : Balboni A; Experimental Imaging Centre, San Raffaele Scientific Institute IRCCS, 20132, Milan, Italy.; D'Angelo C

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/metabolism ; Glioblastoma*/Glioblastoma*/Glioblastoma*/pathology ; Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy

  • Source: Scientific reports [Sci Rep] 2024 Sep 03; Vol. 14 (1), pp. 20421. Date of Electronic Publication: 2024 Sep 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Desert Hedgehog Down-regulation Mediates Inhibition of Proliferation by γ-Glutamylcyclotransferase Knockdown in Murine Glioblastoma Stem Cells.

  • Authors : Mori M; Laboratory of Clinical Oncology, Kyoto Pharmaceutical University, Kyoto, Japan.; Ii H

Subjects: Cell Proliferation* ; Down-Regulation* ; gamma-Glutamylcyclotransferase*/gamma-Glutamylcyclotransferase*/gamma-Glutamylcyclotransferase*/metabolism

  • Source: Cancer genomics & proteomics [Cancer Genomics Proteomics] 2024 Sep-Oct; Vol. 21 (5), pp. 474-484.Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 101188791 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

PHF6 suppresses self-renewal of leukemic stem cells in AML.

  • Authors : Jalnapurkar SS; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.; Pawar AS

Subjects: Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/pathology ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/genetics ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/metabolism

  • Source: Leukemia [Leukemia] 2024 Sep; Vol. 38 (9), pp. 1938-1948. Date of Electronic Publication: 2024 Jul 14.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugs.

  • Authors : Vojnits K; Department of Biochemistry and Biomedical Sciences, Faculty of Health Sciences, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.; Feng Z

Subjects: Neoplastic Stem Cells*/Neoplastic Stem Cells*/Neoplastic Stem Cells*/drug effects ; Neoplastic Stem Cells*/Neoplastic Stem Cells*/Neoplastic Stem Cells*/pathology ; Neoplastic Stem Cells*/Neoplastic Stem Cells*/Neoplastic Stem Cells*/metabolism

  • Source: Cancer letters [Cancer Lett] 2024 Sep 01; Vol. 599, pp. 217108. Date of Electronic Publication: 2024 Jul 08.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways.

  • Authors : Fang T; Engineering Center of Innovativennovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China.; MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China.

Subjects: Erlotinib Hydrochloride*/Erlotinib Hydrochloride*/Erlotinib Hydrochloride*/pharmacology ; Erlotinib Hydrochloride*/Erlotinib Hydrochloride*/Erlotinib Hydrochloride*/administration & dosage ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy

  • Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Sep; Vol. 207 (2), pp. 435-451. Date of Electronic Publication: 2024 Jul 03.Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  44,423 results for ""Neoplastic Stem Cells""